The DOI matches its Crossref record, with a small difference in title or year; 41 of the 41 references it cites were found in a registry or an index.
Maternal Glycemic Control and Hypoglycemia in Type 1 Diabetic Pregnancy
Open accessAbstract
OBJECTIVE—To assess the safety and efficacy of insulin aspart (IAsp) versus regular human insulin (HI) in basal-bolus therapy with NPH insulin in pregnant women with type 1 diabetes. RESEARCH DESIGN AND METHODS—Subjects (n = 322) who were pregnant or planning pregnancy were randomized to IAsp or HI as meal-time insulin in an open-label, parallel-group, multicenter study. Subjects had A1C ≤8% at confirmation of pregnancy. Insulin doses were titrated toward predefined glucose targets and A1C <6.5%. Outcomes assessed included risk of major maternal hypoglycemia, A1C, plasma glucose profiles, and maternal safety outcomes. RESULTS—Major hypoglycemia occurred at a rate of 1.4 vs. 2.1 episodes/year exposure with IAsp and HI, respectively (relative risk 0.720 [95% CI 0.36–1.46]). Risk of major/major nocturnal hypoglycemia was 52% (RR 0.48 [0.20–1.143]; P = NS) lower with IAsp compared with HI. A1C was comparable with human insulin in second (IAsp-HI −0.04 [−0.18 to 0.11]) and third (−0.08 [−0.23 to 0.06]) trimesters. A total of 80% of subjects achieved an A1C ≤6.5%. At the end of first and third trimesters, average postprandial plasma glucose increments were significantly lower with IAsp than HI (P = 0.003 and P = 0.044, respectively), as were mean plasma glucose levels 90 min after breakfast (P = 0.044 and P = 0.001, respectively). Maternal safety profiles and pregnancy outcomes were similar between treatments. CONCLUSIONS—IAsp is at least as safe and effective as HI when used in basal-bolus therapy with NPH insulin in pregnant women with type 1 diabetes and may potentially offer some benefits in terms of postprandial glucose control and preventing severe hypoglycemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“oral agents such as metformin or glyburide have not shown increased adverse pregnancy outcomes and therefore can be considered.1430–1435”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1430]
Experimental — accuracy not yet measuredIn the citing paper
“Rapid-acting insulin analogs are likely more able than regular human insulin to help a woman achieve postprandial blood glucose targets and are less likely to cause hypoglycemia; fetal outcomes, however, seem comparable (28–30).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [29]
In the citing paper
“Rapid-acting insulin analogs are likely more able than regular human insulin to help a woman achieve postprandial blood glucose targets and are less likely to cause hypoglycemia; fetal outcomes, however, seem comparable (28–30).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [29]
In the citing paper
“Rapid-acting insulin analogs are likely more able than regular human insulin to help a woman achieve postprandial blood glucose targets and are less likely to cause hypoglycemia; fetal outcomes, however, seem comparable (28–30).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Multivariate Survival Data
Hougaard, P. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4612-1304-8 · Cited by 1,458
Evers, I. M., de Valk, H. W., & Visser, G. H. A. (2004) · BMJ · doi:10.1136/bmj.38043.583160.ee · Cited by 777
Macintosh, M. C. M., Fleming, K. M., Bailey, J. A., Doyle, P., Modder, J., Acolet, D., Golightly, S., & Miller, A. (2006) · BMJ · doi:10.1136/bmj.38856.692986.ae · Cited by 673
Handbook of Psychology and Diabetes
Bradley, C. (2013) · Routledge eBooks · doi:10.4324/9781315077369 · Cited by 668
de Veciana, M., Major, C. A., Morgan, M. A., Asrat, T., Toohey, J. S., Lien, J. M., & Evans, A. T. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511093331901 · Cited by 666
Casson, I. F., Clarke, C. A., Howard, C. V., McKendrick, O., Pennycook, S., Pharoah, P. O. D., Platt, M. J., Stanisstreet, M., van Velszen, D., & Walkinshaw, S. A. (1997) · BMJ · doi:10.1136/bmj.315.7103.275 · Cited by 522
[Lys(B28), Pro(B29)]-Human Insulin: A Rapidly Absorbed Analogue of Human Insulin
Howey, D. C., Bowsher, R. R., Brunelle, R. L., & Woodworth, J. R. (1994) · Diabetes · doi:10.2337/diab.43.3.396 · Cited by 471
Owens, D. R., Zinman, B., & Bolli, G. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05842-1 · Cited by 375
HbA1c levels are significantly lower in early and late pregnancy
Nielsen, L. R., Ekbom, P., Damm, P., Glümer, C., Frandsen, M. M., Jensen, D. M., & Mathiesen, E. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1200 · Cited by 331
Self-citationSuhonen, L., Hiilesmaa, V., & Teramo, K. (2000) · Diabetologia · doi:10.1007/s001250050010 · Cited by 302
Pregnancy outcomes in the Diabetes Control and Complications Trial
(1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70683-x · Cited by 278
Hawthorne, G., Robson, S., Ryall, E. A., Sen, D., Roberts, S. H., & Platt, M. P. W. (1997) · BMJ · doi:10.1136/bmj.315.7103.279 · Cited by 276
Raskin, P., Guthrie, R. A., Leiter, L. A., Riis, A. H., & Jovanovič, L. (2000) · Diabetes Care · doi:10.2337/diacare.23.5.583 · Cited by 230
Home, P., Olinder, A. L., Riis, A., & for the European Insulin Aspart Study Group (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00380.x · Cited by 230
Olinder, A. L., McEwen, J., & Riis, A. (1999) · Diabetes Care · doi:10.2337/diacare.22.5.801 · Cited by 175
Maternal hypoglycemia during pregnancy in type 1 diabetes: maternal and fetal consequences
ter Braak, E. W. M. T., Evers, I. M., Erkelens, D. W., & Visser, G. H. A. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.271 · Cited by 166
ROSENN, B., MIODOVNIK, M., HOLCBERG, G., KHOURY, J., & SIDDIQI, T. (1995) · Obstetrics & Gynecology · doi:10.1016/0029-7844(94)00415-a · Cited by 161
Evers, I. M., ter Braak, E. W. M. T., de Valk, H. W., van der Schoot, B., Janssen, N., & Visser, G. H. A. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.554 · Cited by 152
Temple, R. C., Aldridge, V., Greenwood, R., Heyburn, P., Sampson, M., & Stanley, K. (2002) · BMJ · doi:10.1136/bmj.325.7375.1275 · Cited by 151
[Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin
Howey, D. C., Bowsher, R. R., Brunelle, R. L., et al. (1994) · Diabetes · doi:10.2337/diabetes.43.3.396 · Cited by 128
Manderson, J. G., Patterson, C., Hadden, D. R., Traub, A. I., Ennis, C. N., & McCance, D. R. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/s0002-9378(03)00497-6 · Cited by 114
Self-citationInsulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus
Persson, B., Swahn, M.-L., Hjertberg, R., Hanson, U., Nord, E., Nordlander, E., & Hansson, L.-O. (2002) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(02)00141-9 · Cited by 103
Severe Hypoglycemia Incidence and Predisposing Factors in 85 Pregnancies of Type I Diabetic Women
Kimmerle, R., Heinemann, L., Delecki, A., & Berger, M. (1992) · Diabetes Care · doi:10.2337/diacare.15.8.1034 · Cited by 96
Heller, S. R., Colagiuri, S., Vaaler, S., Wolffenbuttel, B. H. R., Koelendorf, K., Friberg, H. H., Windfeld, K., & Olinder, A. L. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01244.x · Cited by 96
Self-citationFactors Associated With Preterm Delivery in Women With Type 1 Diabetes
Lepercq, J. A., Coste, J., Théau, A., Dubois‐Laforgue, D., & Timsit, J. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2824 · Cited by 92
Bott, U., Ebrahim, S. H., Hirschberger, S., & Skovlund, S. E. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01010.x · Cited by 85
Progression of retinopathy during pregnancy in type 1 diabetic women treated with insulin lispro
Loukovaara, S., Immonen, I., Teramo, K. A., & Kaaja, R. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1193 · Cited by 80
Tamás, G., Marre, M., Astorga, R., Dedov, I. I., Jacobsen, J. B., & Olinder, A. L. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(01)00262-5 · Cited by 78
HbA1c in healthy, pregnant women.
Radder, J. K., & van Roosmalen, J. (2005) · PubMed · Cited by 73
Heller, S. R., & Macdonald, I. A. (1996) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199607)13:7 · Cited by 71
Pregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog)
Masson, E. A., Patmore, J., Brash, P. D., Baxter, M., Caldwell, G., GALLEN, I. W., Price, P. A., Vice, P., Walker, J. D., & Lindow, S. W. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00840.x · Cited by 66
Perriello, G., Pampanelli, S., Porcellati, F., Avogaro, A., Bosi, E., Petrella, G., Squatrito, S., Furneri, S., Marra, G., Vitali, L., et al. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01473.x · Cited by 54
(2004) · PubMed · Cited by 51
Glycosylated hemoglobin as predictor of adverse fetal outcome in type 1 diabetic pregnancies
Nielsen, G. L., Sørensen, H. T., Nielsen, P. H., Sabroe, S., & Olsen, J. H. (1997) · Acta Diabetologica · doi:10.1007/s005920050077 · Cited by 46
Garg, S. K., Frías, J. P., Anil, S., Gottlieb, P. A., MacKenzie, T. A., & Jackson, W. E. (2003) · Endocrine Practice · doi:10.4158/ep.9.3.187 · Cited by 41
Severe hypoglycemia during pregnancy: Its frequency and predisposing factors in diabetic women
Rayburn, W. F., Piehl, E. J., Jacober, S. J., Schork, A. M., & Ploughman, L. (1986) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(86)90082-2 · Cited by 37
Medical Complications of Diabetes Mellitus in Pregnancy
Rosenn, B., & Miodovnik, M. (2000) · Clinical Obstetrics & Gynecology · doi:10.1097/00003081-200003000-00003 · Cited by 35
When and how to start insulin treatment in gestational diabetes: a UK perspective
Hadden, D. R. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00412.x · Cited by 23
Hellmuth, E., Damm, P., Mølsted‐Pedersen, L., & Bendtson, I. (2000) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2000.079011958.x · Cited by 23
Shared frailty models for recurrent events
Hougaard, P. (2000) · Statistics in the health sciences · doi:10.1007/978-1-4612-1304-8_9 · Cited by 3
Leguizamon (2000) · doi:10.1002/(sici)1520-6661(200001/02)9:1
Flagged first, then by citations
Cited by
Sorted by citations
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J. P., Dralle, H., Ebeling, P. R., Melmed, S. K., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,500
Cryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., & Service, F. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1410 · Cited by 1,277
Self-citationManagement Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C., Hamilton, J. K., HAY, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,273
Hod, M., Kapur, A., Sacks, D. A., Hadar, E., Agarwal, M., Di Renzo, G. C., Roura, L. C., McIntyre, H. D., Morris, J. L., & Divakar, H. (2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(15)30033-3 · Cited by 767
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G. E., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S. E., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.gl · Cited by 646
Metadata
- Authors
- Mathiesen, E. R., Kinsley, B., Amiel, S. A., Heller, S., McCance, D., Duran, S., Bellaire, S., Raben, A., & on behalf of the Insulin Aspart Pregnancy Study Group
- Affiliations
- Rigshospitalet (DK)
- Mater Misericordiae University Hospital (IE)
- King's College London (GB)
- Northern General Hospital (GB)
- Royal Victoria Hospital (GB)
- Unidad de Investigacion Diabetes, Hospital Virgen de Valme, Seville, Spain
- Novo Nordisk (Denmark) (DK)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2007-04-01
- Volume
- 30
- Issue
- 4
- Pages
- 771-776
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2066807346
- Cited by
- 265
- References
- 40
- Citations by year
- 2026: 8 · 2025: 4 · 2024: 6 · 2023: 6 · 2022: 9 · 2021: 13 · 2020: 9 · 2019: 16 · 2018: 14 · 2017: 7 · 2016: 20 · 2015: 24 · 2014: 8 · 2013: 20 · 2012: 23
- FWCI
- 22.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Novo Nordisk
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- insulin aspart, regular insulin, type 1 diabetes in pregnancy, maternal hypoglycemia, multiple daily insulin injections, NPH insulin, glycemic control, HbA1c, postprandial blood glucose, nocturnal hypoglycemia, pregnancy outcomes
- MeSH terms
- Adult, Diabetes Mellitus, Type 1, Drug Administration Schedule, Europe, Female, Gestational Age, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Insulin, Isophane, Pregnancy, Pregnancy Complications, Pregnancy Outcome, Quality of Life, Body Mass Index, Insulin Aspart
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
